리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 08월
페이지 정보:영문 198 Pages
라이선스 & 가격 (부가세 별도)
한글목차
자가 검사 세계 시장은 2030년까지 197억 달러에 달할 전망
2024년에 123억 달러로 추정되는 자가 검사 세계 시장은 2024년부터 2030년까지 CAGR 8.1%로 성장하여 2030년에는 197억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석하고 있는 부문 중 하나인 키트는 CAGR 7.6%를 기록하며 분석 기간 종료시에는 114억 달러에 달할 것으로 예측됩니다. 디바이스 분야의 성장률은 분석 기간 동안 CAGR 9.3%로 추정됩니다.
미국 시장은 32억 달러, 중국은 CAGR 7.9%로 성장 예측
미국의 자가 검사 시장은 2024년에 32억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 7.9%로 성장하여 2030년에는 32억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 7.4%와 7.0%로 예측됩니다. 유럽에서는 독일이 CAGR 약 6.6%로 성장할 것으로 예측됩니다.
세계의 자가 검사 시장 - 주요 동향과 촉진요인 정리
자가 검사 시장이 인기를 끌고 있는 이유는 무엇일까?
자가 검사 시장은 소비자들이 건강 관리를 위해 보다 편리하고, 개인적이며, 빠른 진단 솔루션을 원함에 따라 크게 성장하고 있습니다. 예방적 건강관리에 대한 인식이 높아지고 감염, 불임, 콜레스테롤, 비타민 결핍 등 가정용 검사 키트의 확대가 시장 수요를 견인하고 있습니다. COVID-19 팬데믹으로 인해 가정 내 신속 항원 검사 및 PCR 검사가 널리 사용되면서 자가 검사의 채택이 가속화되었습니다. 진단 기술의 발전으로 자가 검사 키트의 정확도와 사용 편의성이 향상되어 병원을 자주 방문하지 않고도 건강 상태를 조기에 발견할 수 있게 되었습니다. 또한, 원격의료 서비스의 부상으로 자가 검사는 디지털 헬스케어 생태계에 더욱 통합되어 원격지에서 진단 및 치료 제안을 할 수 있게 되었습니다.
어떤 기술 혁신이 자가 검사 키트의 효과를 높이고 있는가?
마이크로유체공학, 바이오센서, 인공지능(AI)을 활용한 진단의 최근 기술 혁신은 자가진단 기기의 정확성과 사용 편의성을 크게 향상시키고 있습니다. 랩온칩 기술은 소량의 혈액, 타액, 소변 샘플로 정밀한 생화학 분석이 가능한 소형의 비용 효율적인 검사 솔루션을 제공합니다. 블루투스와 스마트폰 연결이 가능한 스마트 자가 검사 키트는 검사 결과를 실시간으로 추적할 수 있으며, 사용자는 의료진과 즉시 데이터를 공유할 수 있습니다. AI 기반 이미지 인식의 통합은 측면 흐름 검사의 해석을 더욱 강화하여 사용자 오류의 위험을 줄입니다. 또한, 비침습적 자가 진단 방법의 발전으로 호흡 기반 포도당 모니터, 타액 기반 유전자 검사 등 비침습적 자가 진단 방법이 발전하면서 재택 진단의 범위가 넓어지고 있습니다.
자가 검사 시장의 성장을 주도하는 헬스케어 분야는?
자가진단 키트는 감염 검진, 만성질환 관리, 맞춤형 의료 등 다양한 헬스케어 분야에서 널리 사용되고 있습니다. 당뇨병 분야는 자가 검사 장치의 가장 큰 소비자 중 하나이며, 연속 혈당 모니터링(CGM) 시스템과 혈당 검사 스트립은 일상적인 질병 관리에 필수적입니다. 여성 건강 분야도 성장하고 있으며, 불임 검사 및 임신 테스트 키트가 더욱 진화하고 널리 활용되고 있습니다. 가족력이나 DNA를 통한 건강 위험도 평가 등 유전적 자가 진단의 증가는 가정 내 진단에 대한 소비자의 관심을 더욱 확대시키고 있습니다. 또한, 예방적 헬스케어에 대한 관심이 높아지면서 콜레스테롤, 심혈관 위험 평가, 장내 미생물 분석과 같은 자가 검사 솔루션에 대한 수요가 증가하고 있습니다.
자가 검사 시장의 성장을 촉진하는 요인은 무엇인가?
자가 검사 시장의 성장은 건강 인식의 증가, 예방적 건강 관리로의 전환, 진단 기술의 향상 등 여러 가지 요인에 의해 이루어집니다. E-Commerce와 DTC(Direct-to-Consumer) 헬스케어 브랜드가 확대되면서 자가 검사 키트는 전 세계 소비자들에게 더욱 친숙하게 다가서고 있습니다. 가정용 진단기기에 대한 정부의 승인과 상환 정책의 개선은 시장 확대를 더욱 촉진하고 있습니다. 원격의료와 디지털 헬스 플랫폼의 통합도 자가 검사 키트의 수요를 촉진하고 있습니다. 자가 검사 키트는 환자의 원격 모니터링이 가능하여 의료 시설의 부담을 줄일 수 있습니다. 자가 검사 기술이 계속 발전함에 따라 보다 개인화되고 효율적인 헬스케어 솔루션이 제공되어 시장이 확대될 것으로 예상됩니다.
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Self-Testing Market to Reach US$19.7 Billion by 2030
The global market for Self-Testing estimated at US$12.3 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$11.4 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 9.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 7.9% CAGR
The Self-Testing market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.
Global Self-Testing Market - Key Trends & Drivers Summarized
Why Is The Self-Testing Market Gaining Popularity?
The self-testing market is witnessing significant growth as consumers seek more convenient, private, and rapid diagnostic solutions for managing their health. The increasing awareness of preventive healthcare, along with the expansion of home-based testing kits for infectious diseases, fertility, cholesterol, and vitamin deficiencies, is driving market demand. The COVID-19 pandemic accelerated the adoption of self-testing, with at-home rapid antigen and PCR tests becoming widely available. With advancements in diagnostic technology, self-testing kits are becoming more accurate and user-friendly, enabling early detection of health conditions without the need for frequent hospital visits. Additionally, the rise of telehealth services is further integrating self-testing into digital healthcare ecosystems, allowing for remote consultation and treatment recommendations.
What Innovations Are Enhancing The Effectiveness Of Self-Testing Kits?
Recent innovations in microfluidics, biosensors, and artificial intelligence (AI)-powered diagnostics are significantly improving the accuracy and usability of self-testing devices. Lab-on-a-chip technology is enabling compact and cost-effective testing solutions, allowing for precise biochemical analysis from a small sample of blood, saliva, or urine. Smart self-testing kits equipped with Bluetooth and smartphone connectivity are allowing real-time tracking of test results, enabling users to share data with healthcare providers instantly. The integration of AI-based image recognition is further enhancing the interpretation of lateral flow tests, reducing the risk of user error. Additionally, advancements in non-invasive self-testing methods, such as breath-based glucose monitors and saliva-based genetic testing, are expanding the scope of home diagnostics.
Which Healthcare Segments Are Driving The Growth Of The Self-Testing Market?
Self-testing kits are becoming widely adopted across multiple healthcare sectors, including infectious disease screening, chronic disease management, and personalized medicine. The diabetes sector remains one of the largest consumers of self-testing devices, with continuous glucose monitoring (CGM) systems and blood sugar test strips being essential for daily disease management. The women’s health segment is also experiencing growth, with fertility and pregnancy test kits becoming more advanced and widely available. The rise of genetic self-testing, including ancestry and DNA health risk assessments, is further expanding consumer interest in at-home diagnostics. Additionally, the growing focus on preventive healthcare is increasing demand for self-testing solutions for cholesterol, cardiovascular risk assessment, and gut microbiome analysis.
What Factors Are Fueling The Growth Of The Self-Testing Market?
The growth of the self-testing market is driven by several factors, including increased health awareness, the shift toward preventive healthcare, and improvements in diagnostic technology. The expansion of e-commerce and direct-to-consumer (DTC) healthcare brands is making self-testing kits more accessible to consumers worldwide. Government approvals for at-home diagnostic devices, along with improved reimbursement policies, are further supporting market expansion. The integration of telemedicine and digital health platforms is also driving demand for self-testing kits, as they enable remote patient monitoring and reduce the burden on healthcare facilities. As self-testing technology continues to evolve, the market is expected to expand, offering more personalized and efficient healthcare solutions.
SCOPE OF STUDY:
The report analyzes the Self-Testing market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 44 Featured) -
2San
Abbott Laboratories
Access Bio, Inc.
ACON Laboratories, Inc.
ARKRAY, Inc.
Assure Tech (Hangzhou) Co., Ltd.
Becton, Dickinson and Company (BD)
bioLytical Laboratories Inc.
Bionime Corporation
BioReference Laboratories, Inc.
Biozek Medical
Cardinal Health
Celltrion Inc.
Eurofins Scientific
Everlywell, Inc.
F. Hoffmann-La Roche Ltd.
Geratherm Medical AG
Gold Standard Diagnostics
iHealth Labs Inc.
iuvo BioScience
Johnson & Johnson Services, Inc.
LetsGetChecked
Nectar Lifesciences Ltd.
OraSure Technologies, Inc.
PRIMA Lab SA
Quidel Corporation
Selfdiagnostics
Siemens Healthineers
True Diagnostics, Inc.
Wondfo
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Self-Testing - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Convenient and At-Home Health Solutions Drives Growth in Self-Testing Products
The Rise of Chronic Disease Management and Preventative Healthcare Expands Market Opportunity for Self-Testing Solutions
Surge in Consumer Awareness of Health and Wellness Drives Adoption of Self-Testing Kits for Home Use
Technological Advancements in Diagnostics and Testing Devices Propel Market Growth for Self-Testing Products
Growing Preference for Privacy and Confidentiality in Health Management Strengthens the Demand for Self-Testing Solutions
The Expansion of Remote Healthcare and Telemedicine Services Creates New Opportunities for Self-Testing Products
Increasing Regulatory Approvals and Standards for Self-Testing Devices Accelerates Consumer Confidence and Market Growth
The Growth of the Wellness and Fitness Sector Strengthens the Adoption of Self-Testing for Health Metrics
Rising Healthcare Costs Drive Demand for Affordable, At-Home Testing Solutions for Chronic Conditions
Increasing Investment in Digital Health and Mobile Health Apps Expands the Role of Self-Testing in Remote Monitoring
Consumer Demand for Real-Time, Actionable Health Data Drives the Growth of Self-Testing Kits in Multiple Market Segments
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Self-Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Cholesterol & Triglycerides Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Cholesterol & Triglycerides Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Pregnancy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Pregnancy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for STD Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for STD Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Urinary Tract Infection Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Urinary Tract Infection Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Cancer Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Cancer Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Celiac disease Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Celiac disease Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Thyroid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Thyroid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Transaminase Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Transaminase Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Anemia Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Anemia Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Allergy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Allergy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Blood Pressure Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World 6-Year Perspective for Blood Pressure Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Diabetes & Glucose Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 35: World 6-Year Perspective for Diabetes & Glucose Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 36: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 37: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World 6-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Stool by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 41: World 6-Year Perspective for Stool by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 42: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 43: World 6-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 46: USA Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: USA 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 48: USA Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: USA 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
CANADA
TABLE 50: Canada Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 52: Canada Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: Canada 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 54: Canada Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: Canada 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
JAPAN
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 58: Japan Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Japan 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 60: Japan Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Japan 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
CHINA
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: China 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 64: China Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: China 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 66: China Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: China 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
EUROPE
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 68: Europe Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 69: Europe 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 70: Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 72: Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
FRANCE
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 76: France Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: France 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 78: France Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: France 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: France 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
GERMANY
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 82: Germany Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: Germany 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 84: Germany Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: Germany 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Germany 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
ITALY
TABLE 88: Italy Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Italy 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 90: Italy Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Italy 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Italy 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
UNITED KINGDOM
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 94: UK Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: UK 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 96: UK Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 97: UK 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 98: UK Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: UK 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
REST OF EUROPE
TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 101: Rest of Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 103: Rest of Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
ASIA-PACIFIC
Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 107: Asia-Pacific 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 109: Asia-Pacific 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Asia-Pacific 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
REST OF WORLD
TABLE 112: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 113: Rest of World 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
TABLE 114: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 115: Rest of World 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
TABLE 116: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Rest of World 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030